Seer Inc grabs $55 mln Series D

South San Francisco-based Seer Inc, a life sciences company focused on capturing and translating proteome insights to advance human health, has raised $55 million in Series D equity financing.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this